|
Market Closed -
Bombay S.E.
06:26:01 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 1,482.45 INR | -3.21% |
|
-7.04% | +90.30% |
| 08-09 | Indian shares set to gain as soft US jobs data offsets oil worries | RE |
| 08-07 | Novartis India Limited Terminates Distribution and Promotion Agreement with Dr. Reddy?S Laboratories Limited | CI |
| Market Cap | 23.97B 251M 215M 201M 184M 347M 352M 2.37B 928M 12.02B 942M 921M 39.75B | P/E 2024 |
29.8x | P/E 2025 | 19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 17.65B 185M 158M 148M 136M 255M 259M 1.75B 683M 8.85B 693M 678M 29.27B | EV / Sales 2024 |
5.85x | EV / Sales 2025 | 3.67x |
| Free-Float |
41.32% | Yield 2024 |
2.43% | Yield 2025 | 3.18% |
| 1 day | -3.21% | ||
| 1 week | -7.04% | ||
| Current month | -4.01% | ||
| 1 month | -5.59% | ||
| 3 months | +22.62% | ||
| 6 months | +78.51% | ||
| Current year | +90.30% |
| 1 week | 1,480.05 |  | 1,643.9 |
| 1 month | 1,480.05 | | 1,777.5 |
| Current year | 750 | | 1,777.5 |
| 1 year | 750 | | 1,777.5 |
| 3 years | 599.95 | | 1,777.5 |
| 5 years | 554 | | 1,777.5 |
| 10 years | 420.05 | | 1,777.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | - | 2026-07-29 |
Chandni Maru
CMP | Compliance Officer | - | 2024-05-07 |
Amitabh Dube
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ashok Bhatia
BRD | Director/Board Member | 72 | 2026-07-28 |
| Director/Board Member | - | 2026-07-28 | |
Jagriti Gupta
BRD | Director/Board Member | - | 2026-07-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.21% | -7.04% | +55.85% | +110.34% | 396M | |
| -0.85% | +5.16% | +80.22% | +131.13% | 1,141B | |
| -0.61% | +3.98% | +52.38% | +62.84% | 659B | |
| -0.27% | +5.86% | +26.95% | +76.82% | 470B | |
| +1.20% | +2.62% | +41.69% | +46.21% | 366B | |
| -0.61% | +2.10% | +23.43% | +40.38% | 302B | |
| +0.32% | +3.25% | +0.94% | +13.25% | 254B | |
| -1.33% | +4.53% | +47.34% | +67.54% | 239B | |
| -1.10% | -0.70% | -14.31% | -53.04% | 207B | |
| -1.07% | +5.95% | +23.27% | +92.73% | 183B | |
| Average | -0.78% | +3.30% | +33.78% | +58.82% | 382.14B | |
| Weighted average by Cap. | -0.52% | +4.31% | +45.52% | +73.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.35B 35.06M 30.07M 28.08M 25.76M 48.45M 49.24M 331M 130M 1.68B 132M 129M 5.56B | 3.56B 37.27M 31.97M 29.86M 27.39M 51.51M 52.36M 352M 138M 1.79B 140M 137M 5.91B |
| Net income | 852M 8.91M 7.65M 7.14M 6.55M 12.32M 12.52M 84.24M 32.99M 427M 33.47M 32.74M 1.41B | 1.01B 10.56M 9.06M 8.46M 7.76M 14.59M 14.83M 99.77M 39.07M 506M 39.64M 38.77M 1.67B |
| Net Debt | -5.78B -60.47M -51.87M -48.44M -44.44M -83.57M -84.95M -572M -224M -2.9B -227M -222M -9.58B | -6.32B -66.12M -56.72M -52.96M -48.59M -91.38M -92.88M -625M -245M -3.17B -248M -243M -10.48B |
Employees
56
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-20 | ₹1,482.45 | -3.21% | 2,981 |
| 26-08-19 | ₹1,531.55 | -3.92% | 1,026 |
| 26-08-18 | ₹1,594.05 | +0.31% | 928 |
| 26-08-17 | ₹1,589.20 | +0.16% | 2,372 |
| 26-08-14 | ₹1,586.70 | +2.30% | 1,104 |
- Stock Market
- Stocks
- NOVARTIND Stock
Select your edition
All financial news and data tailored to specific country editions
